ASRC Press Releases

NARB Panel Recommends Reckitt Benckiser Discontinue Challenged ‘8-Minute’ Relief Claims for Mucinex, Maximum Strength Mucinex

A NARB panel has recommended that Reckitt Benckiser, LLC (RB) discontinue challenged advertising claims for the company’s Mucinex and Maximum Strength Mucinex bi-layer tablet products.

Read More

NAD Recommends AT&T Modify Certain ‘U-Verse’ Ads to Better Disclose Limitations of Service, Discontinue TV Spots; Finds Advertiser Provided ‘Reasonable Basis’ for Speed Claim

The NAD has recommended that AT&T Services, Inc., modify disclosures that accompany certain advertised Internet speed claims made for the company’s U-verse service.

Read More

ERSP Recommends Universal Commerce Modify Advertising for ‘Senior Mobile’ Cell Phone to Better Disclose Activation Fee

ERSP has recommended that Universal Commerce modify certain advertising claims for Senior Mobile, a cell phone designed for seniors, to better disclose that the free phone carries a $97 activation fee.

Read More

CARU Recommends BSA Modify Website to Better Protect Children’s Privacy; BSA Agrees to Do So

CARU has recommended that Boys Scouts of America modify its website,, to assure that information collection practices are in compliance with CARU guidelines and the Children’s Online Privacy Protection Act (COPPA).

Read More

NAD Recommends ‘LifeCaps’ Discontinue all Claims Challenged by CRN

The National Advertising Division has recommended that LifeCaps Neutraceuticals, LLC, discontinue all challenged advertising claims for the company’s “LifeCaps,” a dietary supplement promoted as a “survival pill.”

Read More Commits to Discontinue Claim that Garcinia Cambogia Product May Fight Ebola, contacted by the NAD in the course of a challenge to certain advertising claims for the company’s “Garcinia Cambogia Powder with 50% HCA Dietary Supplements” has advised NAD that it is permanently discontinuing challenged claims for the product, including: “Some of the possible health benefits of Garcinia Cambogia [are that it]… fights… [the] ebola virus.”

Read More